MedTrace Logo

Glycemic Response in Adults With Type 2 Diabetes

NCT05166200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2022-06-28

No results posted yet for this study

Summary

This is a randomized, controlled, crossover study to compare the effects of two treatments on postprandial glucose in adults with type 2 diabetes.

Conditions

  • Glycemic Control

Interventions

OTHER

Experimental Formula

Diabetes-specific study formula

OTHER

Test Meal

Instant oatmeal

Sponsors & Collaborators

  • Abbott Nutrition

    lead INDUSTRY

Principal Investigators

  • Sara Thomas, PhD, RDN · Abbott Nutrition

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-11
Primary Completion
2022-06-20
Completion
2022-06-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05166200 on ClinicalTrials.gov